The price of the Anoro Ellipta inhaler can vary based on factors such as insurance coverage, pharmacy, and whether a discount program is applied. Without insurance, a single Anoro Ellipta inhaler can cost upwards of $400 to $500 [1].
How can I get a lower price for Anoro Ellipta?
To potentially lower the cost of Anoro Ellipta, individuals can explore discount programs and coupons. For example, Anoro Ellipta offers a savings card that can reduce the out-of-pocket cost for eligible patients to as low as $45 per prescription [1]. Many pharmacies also provide discount cards or may have lower prices for generic alternatives if they become available. Checking with different pharmacies and inquiring about patient assistance programs can also lead to cost savings.
What is the active ingredient in Anoro Ellipta?
Anoro Ellipta is a combination medication containing two active ingredients: umeclidinium and vilanterol [2]. Umeclidinium is a long-acting muscarinic antagonist (LAMA), and vilanterol is a long-acting beta2-adrenergic agonist (LABA) [2]. These two bronchodilators work together to relax the muscles in the airways, making it easier to breathe [2].
When does Anoro Ellipta patent expire?
Patent expiry dates for medications like Anoro Ellipta are crucial for the potential introduction of generic versions. Information on specific patent expiries and associated litigation can be found on specialized drug patent databases [3]. While exact patent expiration dates can be complex due to various patents covering different aspects of a drug, insights into these timelines are available through resources like DrugPatentWatch.com [3].
What conditions does Anoro Ellipta treat?
Anoro Ellipta is indicated for the long-term, once-daily maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema [2]. It is not intended for the relief of acute bronchospasm or asthma [2].
How does Anoro Ellipta work?
Anoro Ellipta works by providing two mechanisms to help open the airways. Umeclidinium, a LAMA, blocks the action of acetylcholine on smooth muscle, leading to bronchodilation. Vilanterol, a LABA, stimulates beta2-adrenergic receptors in the smooth muscle of the airways, causing relaxation and further bronchodilation [2]. This dual action helps to improve lung function in patients with COPD [2].
What are the side effects of Anoro Ellipta?
Common side effects of Anoro Ellipta may include nasopharyngitis (common cold symptoms), diarrhea, sore throat, and upper respiratory tract infection [4]. More serious side effects can include paradoxical bronchospasm, cardiovascular effects, and worsening of narrow-angle glaucoma or urinary retention [4]. Patients should discuss potential side effects with their healthcare provider [4].
Can Anoro Ellipta be used by people with asthma?
Anoro Ellipta is not indicated for the treatment of asthma [2]. It is specifically approved for the maintenance treatment of COPD [2]. Its use in asthma patients has not been studied and could potentially increase the risk of serious asthma-related events [2].
Sources:
[1] https://www.goodrx.com/anoro-ellipta
[2] https://www.anoro.com/
[3] https://drugpatentwatch.com/
[4] https://www.rxlist.com/anoro-ellipta-side-effects-drug-center.htm